2026644-48-2
2026644-48-2
Chemical Structure
Trilostane-d3-1
Synonym(s): Win 24540-d3-1
- CAS No.: 2026644-48-2
- Formula:C20H24D3NO3
- Molecular Weight:332.45
InChIKey: KVJXBPDAXMEYOA-FBIDWCRQSA-N
SMILES: OC1=C(C#N)C[C@@]2(C([2H])([2H])[2H])[C@@]3(CC[C@]4([H])[C@]2([H])CC[C@@]5(C)[C@@]4([H])CC[C@@H]5O)[C@@H]1O3
Biological Activity: Trilostane-d3-1 (Win 24540-d3-1) is deuterium-labeled Trilostane (HY-14281)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Trilostane-d3-1 | Trilostane-d3-1 (Win 24540-d3-1) is deuterium-labeled Trilostane (HY-14281). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Trilostane (Standard) | ≥98% | Trilostane (Standard) is the analytical standard of Trilostane. This product is intended for research and analytical applications. Trilostane (Win 24540) is a competitive and orally active 3-β-hydroxysteroiddehydrogenase (3β-HSD) inhibitor. Trilostane is a synthetic nonhormonal steroid. Trilostane can be used for the research of breast cancer and prostate cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Trilostane-15N,d3 | Trilostane-15N,d3 (Win 24540-15N,d3) is the deuterium labeled Trilostane (HY-14281). Trilostane (Win 24540) is a competitive and orally active 3-β-hydroxysteroiddehydrogenase (3β-HSD) inhibitor. Trilostane is a synthetic nonhormonal steroid. Trilostane can be used for the research of breast cancer and prostate cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Trilostane-d3 | Trilostane-d3 is the deuterium-labeled Trilostane (HY-14281). Trilostane-d3 (Win 24540) is a competitive and orally active 3-β-hydroxysteroiddehydrogenase (3β-HSD) inhibitor. Trilostane-d3 is a synthetic nonhormonal steroid. Trilostane-d3 can be used for the research of breast cancer and prostate cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Trilostane | 99.94% | Trilostane (Win 24540) is a competitive and orally active 3-β-hydroxysteroiddehydrogenase (3β-HSD) inhibitor. Trilostane is a synthetic nonhormonal steroid. Trilostane can be used for the research of breast cancer and prostate cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
